These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 23620311)
1. Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation. Safouris A; Anagnostis P; Karlovasitou A; Karras S; Karagiannis A Angiology; 2014 May; 65(5):372-8. PubMed ID: 23620311 [TBL] [Abstract][Full Text] [Related]
2. A review of oral anticoagulants in patients with atrial fibrillation. Greenspon AJ Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134 [TBL] [Abstract][Full Text] [Related]
3. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
4. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
5. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation. Deitelzweig S Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252 [TBL] [Abstract][Full Text] [Related]
6. Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based study. Joppi R; Cinconze E; Mezzalira L; Pase D; Poggiani C; Rossi E; Pengo V; Eur J Intern Med; 2013 Jun; 24(4):318-23. PubMed ID: 23528931 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation. Senoo K; Lip GY Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085 [TBL] [Abstract][Full Text] [Related]
8. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study. Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P; BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802 [TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814 [TBL] [Abstract][Full Text] [Related]
10. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease. Cairns JA; McMurtry MS Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600 [TBL] [Abstract][Full Text] [Related]
11. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Mooe T Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861 [No Abstract] [Full Text] [Related]
12. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516 [TBL] [Abstract][Full Text] [Related]
16. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation. Aguilar MI; Kuo RS; Freeman WD Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498 [TBL] [Abstract][Full Text] [Related]
17. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607 [TBL] [Abstract][Full Text] [Related]
18. Beyond warfarin: a patient-centered approach to selecting novel oral anticoagulants for stroke prevention in atrial fibrillation. Patel KK; Mehdirad AA; Lim MJ; Ferreira SW; Mikolajczak PC; Stolker JM J Hosp Med; 2014 Jun; 9(6):400-6. PubMed ID: 24715600 [TBL] [Abstract][Full Text] [Related]
19. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation? Lip GY J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]